Drug Profile
Research programme: streptococcal cysteine proteinase inhibitors - Active Biotech
Alternative Names: Streptococcal cysteine proteinase inhibitors - Active BiotechLatest Information Update: 06 Nov 2001
Price :
$50
*
At a glance
- Originator Active Biotech
- Class
- Mechanism of Action Streptococcal cysteine proteinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Staphylococcal infections
Most Recent Events
- 06 Nov 2001 Discontinued-Preclinical for Staphylococcal infections in United Kingdom (Unknown route)
- 14 Dec 2000 Actinova has been closed down
- 14 Dec 2000 Suspended-Preclinical for Staphylococcal infections in United Kingdom (Unknown route)